Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicotine 1.5mg lozenges sugar free
0410020B0AABPBP
|
Nicotine | Nicotine | Central Nervous System | 231 |
|
Tephine 200microgram sublingual tablets
0407020B0BFAAAB
|
Tephine | Buprenorphine | Central Nervous System | 231 |
|
Zyprexa 20mg tablets
040201060BBAKAQ
|
Zyprexa | Olanzapine | Central Nervous System | 231 |
|
Galzemic 4mg/ml oral solution
0411000F0BIADAD
|
Galzemic | Galantamine | Central Nervous System | 229 |
|
Mirapexin 1.05mg modified-release tablets
0409010W0BBAGAG
|
Mirapexin | Pramipexole | Central Nervous System | 228 |
|
Yemex 25micrograms/hour transdermal patches
0407020A0BVABAE
|
Yemex | Fentanyl | Central Nervous System | 228 |
|
Neupro 2mg/24hours transdermal patches
0409010Z0BBAAAA
|
Neupro | Rotigotine | Central Nervous System | 227 |
|
Nicotinell Mint 2mg medicated chewing gum
0410020B0BCAEBA
|
Nicotinell | Nicotine | Central Nervous System | 227 |
|
Orap 4mg tablets
0402010R0BBABAB
|
Orap | Pimozide | Central Nervous System | 227 |
|
Venladex XL 75mg tablets
0403040W0BZABAJ
|
Venladex | Venlafaxine | Central Nervous System | 227 |
|
Pethidine 100mg/2ml solution for injection ampoules
0407020V0AAAEAE
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | 226 |
|
Eslicarbazepine 50mg/1ml oral suspension sugar free
0408010AIAAACAC
|
Eslicarbazepine acetate | Eslicarbazepine acetate | Central Nervous System | 225 |
|
Fycompa 8mg tablets
0408010AKBBADAD
|
Fycompa | Perampanel | Central Nervous System | 225 |
|
Midazolam 7.5mg/0.75ml oromucosal soln pf oral syringes SF
0408020V0AAAWAW
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 225 |
|
Palexia SR 150mg tablets
0407020AGBBAEAE
|
Palexia | Tapentadol | Central Nervous System | 225 |
|
Panitaz 20micrograms/hour transdermal patches
0407020B0BLACAJ
|
Panitaz | Buprenorphine | Central Nervous System | 225 |
|
Risperdal 500microgram tablets
040201030BBAGAK
|
Risperdal | Risperidone | Central Nervous System | 225 |
|
Aricept 10mg tablets
0411000D0BBABAB
|
Aricept | Donepezil hydrochloride | Central Nervous System | 224 |
|
Comtess 200mg tablets
0409010V0BBAAAA
|
Comtess | Entacapone | Central Nervous System | 224 |
|
Lyrica 20mg/ml oral solution
0408010AEBBAIAN
|
Lyrica | Pregabalin | Central Nervous System | 224 |
|
Paracetamol 250mg/5ml oral suspension 5ml sachets sugar free
0407010H0AADEDE
|
Paracetamol | Paracetamol | Central Nervous System | 223 |
|
Primidone 125mg tablets
0408010U0AABDBD
|
Primidone | Primidone | Central Nervous System | 223 |
|
Granisetron 3.1mg/24hours transdermal patches
0406000AFAAAAAA
|
Granisetron | Granisetron | Central Nervous System | 222 |
|
Tapentadol 20mg/ml oral solution sugar free
0407020AGAAAHAH
|
Tapentadol | Tapentadol | Central Nervous System | 222 |
|
Tramadol 37.5mg / Paracetamol 325mg efferv tab sugar free
040702040AABABA
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 222 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.